ARL9 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-25286
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (91%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody has been engineered to specifically recognize the recombinant protein ARL9 using the following amino acid sequence: KQDLEAAYHITDIHEALALSEVGNDRKMFLFGTYLTKNGSEIPSTMQDAKDLIA
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for ARL9 Antibody
Immunocytochemistry/Immunofluorescence: ARL9 Antibody [NBP3-25286]
Staining of human cell line U2OS shows localization to plasma membrane & centriolar satellites.Applications for ARL9 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 µg/ml
Application Notes
For ICC/IF, we recommend using a combination of PFA and Triton X-100. This will give you the optimal results for your experiments.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ARL9
Alternate Names
ADP-ribosylation factor-like 9, ADP-ribosylation factor-like protein 9
Gene Symbol
ARL9
Additional ARL9 Products
Product Documents for ARL9 Antibody
Product Specific Notices for ARL9 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...